Krista D Gregg, CCC- SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7359 Dibble Ave Northwest, Seattle, WA 98117 Phone: 206-930-6959 |
Michele Anne Turk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Columbian Way, Seattle, WA 98108 Phone: 847-894-7056 |
Mrs. Holly Davis, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1433 Nw 64th St Apt 306, Seattle, WA 98107 Phone: 720-984-9154 |
Elaina M Silveri, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2205 N 45th St Unit A, Seattle, WA 98103 Phone: 206-547-2500 Fax: 206-547-9775 |
In Bloom Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7624 39th Ave S, Seattle, WA 98118 Phone: 206-601-0781 |
Joyce Roach Hedges, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 9th Ave, Box 359827, Seattle, WA 98104 Phone: 206-731-3000 |
Mr. Seth Bruce Miller, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11014 39th Ave Ne, Seattle, WA 98125 Phone: 206-363-6487 |
Mrs. Chaya Lintz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5111 S Morgan St, Seattle, WA 98118 Phone: 206-717-2171 |
Mrs. Mary Ellen Talley, MSPA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2445 3rd Ave S, Seattle, WA 98134 Phone: 206-252-1021 |
Dawn Simmons, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6039 4th Ave Nw, Seattle, WA 98107 Phone: 206-380-4422 |
Adaptive Brain Speech Therapy, Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5057 Harold Pl Ne, Seattle, WA 98105 Phone: 425-331-9063 |
Juli E. Rosenzweig, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Box 356490, Seattle, WA 98195 Phone: 206-598-4830 Fax: 206-598-7740 |
Terese V Mccoy, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 |
Mrs. Kimberly Ann Lincoln, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 |
Matthew Mcfarland, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 1st Ave N Ste 200, Seattle, WA 98109 Phone: 206-859-5030 |
Mr. Ilan R Speizer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hazel Wolf K-8, 11530 12th Ave Ne, Seattle, WA 98125 Phone: 206-294-0443 |
Emily Clare Hansen, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5057 Harold Pl Ne, Seattle, WA 98105 Phone: 414-334-9594 |
Lynn D. Farrier, MCSD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-4830 Fax: 206-598-4897 |
Leslie A. Kot, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 9th Ave, Box 359819, Seattle, WA 98104 Phone: 206-731-3000 |
Heidi J Wade, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1625 19th Ave, Seattle, WA 98122 Phone: 206-323-5770 |
News Archive
Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.
A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
New evidence that women are more likely to be harmed than helped by screening tests for ovarian cancer is disturbing. The tests do nothing to prevent healthy women from dying from the usually fatal disease. Yet they often lead doctors to perform needless surgeries that cause serious complications in many patients.
› Verified 4 days ago